GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease
PHASE2
This study will evaluate the safety, biomarkers, and efficacy of tominersen...
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139)
PHASE2
This study will test the safety, tolerability, pharmacokinetics and pharmac...
Status
Completed
Location
The University of British Columbia; The Centre for Huntington Disease
A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease
PHASE1
Study BP40410 is an open-label, adaptive multiple-dose clinical study desig...
An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies
PHASE3
This study will evaluate the long-term safety and tolerability of RO7234292...